Ragweed Allergy Nasal Spray Study
Cliantha Research, Patient Recruitment
The purpose of this study is to assess the onset of effectiveness of a nasal spray (marketed in the USA) in treating allergy symptoms caused by ragweed pollen in an Environmental Exposure Chamber (EEC) compared to a placebo. Study Ref: 19-SB-001.
Eligibility Criteria
Male, Female
18 to 65 years old
allergic rhinitis to ragweed for at least the last 2 years
If smoker, cannot smoke more than 26 cigarettes per day
Cannot be symptomatic to dust mites/mold
Study Tasks
Informed Consent Form
Vital signs
Demographics
Medical/Surgical history
Review of prior/concomitant medications
Skin Prick Test
Ethics
This study has been approved by Advarra Ethics Board.
Keywords
Ragweed allergy
clinical research
nasal symptoms
Activity and Time
Investigational Medicine
Clinical Trial
Weekdays, Weekends
4 hour(s) - 9.5 hour(s) per session
6 session(s)
Up to 6 visits (including medical screening and follow-up visit)
Compensation
Up to $2300
Study Address
4500 Dixie Road Mississauga, Ontario, Canada, L4W 1V7
Earn $2300